Macrogen (038290.KQ) Stock Price

Macrogen Price

CLOSED
11,300.00
​
Market closed

Over the last 19 years Macrogen grew revenue by 15.5% annually, reaching 195.27 B KRW. Earnings per share have grown at 12.7% per year over the last 18 years. For Macrogen, the net margin of 1.0% is broadly stable versus 0.9% a few years ago. At today's price the dividend yield works out to roughly 2.65%. The payout ratio is around 135% of earnings.

Macrogen stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Macrogen business model & stock analysis

Macrogen, Inc. engages in the provision genetic research and biotechnology services. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-02-22. The firm operates its business through four divisions: deoxyribonucleic acid (DNA) sequencing division, DNA chips division, transgenic and knockout mouse division and oligonucleotide DNA division. Its DNA sequencing division provides genome sequencing analysis services. Its DNA chips division develops DNA chips products, such as Illumina chips, MacArray chips and customized chips. Its transgenic and knockout mouse division offers gene engineering services. Its oligonucleotide DNA division offers oligonucleotide DNA manufacturing services. The firm operates its business within domestic market and in overseas markets.

Frequently asked questions about Macrogen

5 analysts currently rate the Macrogen stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Macrogen to generate revenue of 241.10 B KRW and earnings per share of 947.57 KRW.

Converted at the current exchange rate, the Macrogen share trades at 7.55 EUR (11,300.00 KRW).

The expected revenue of Macrogen is 241.10 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Macrogen is 10.27 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Macrogen is currently 11.93. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Macrogen stock.

The price-to-sales ratio (P/S) of Macrogen is currently 0.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Macrogen stock.

The Eulerpool Quality Score for Macrogen is 3/10.

The ISIN of Macrogen is KR7038290003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Macrogen is 038290.KQ. The ticker symbol is used to trade Macrogen shares on the stock exchange.

Fair ValueTerminal
10,396.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website macrogen.com
Country
South Korea
Currency
KRW
Initial public offering
Feb 22, 2000
ISIN
KR7038290003
Cusip
Y5370R104
Market capitalization
112.92 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
10.99
P/Ee 2027
5.08
P/S
P/Se
0.51
EV/EBIT
451.62
P/B Ratio
0.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.17 %
Dividend
Dividend yield
2.65 %
Est. Dividend Yield
2.65 %
Payout Ratio
135.07 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Oct 15, 2026, 9:48 AM

Macrogen Peer Group

Macrogen FIGI

038290:KS · BBG000CC0SY0038290:KQ · BBG000CC0TW0

All fundamentals and in-depth analysis of Macrogen

Our stock analysis for Macrogen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Macrogen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.